In January 2023 the decision to discontinue the remaining presentations of Insuman® regular human, isophane and isophane pre-mixed insulins in the UK, phased over the following 6 months, was announced.
Unfortunately, due to unexpected capacity and component part constraints at plant, Sanofi is expected to discontinue the following products by the end of February 2023:
Endoscopic proximal intestinal exclusion can improve non-alcoholic fatty liver disease (NAFLD) in patients with diabesity
Authors
Hayee B, Sen Gupta P, Anderson M , Fogden E , Roy AA , Butler DB , Bajwa RS , Amiel SA , Ryder REJ
One Year Efficacy, Safety and Tolerability Outcomes of Endoscopic Duodenal Exclusion using Endobarrier as an Adjunct to Glucagon-like Peptide-1 (GLP-1) therapy in Suboptimally Controlled Type 2 Diabetes: a Randomised Controlled Trial
Authors
E Fogden*, P Sen Gupta, M Anderson, B Hayee, RS Drummond, BM McGowan, SA Amiel, REJ Ryder
One Year Efficacy, Safety and Tolerability Outcomes of Endoscopic Duodenal Exclusion Using Endobarrier as an Adjunct to Glucagon-like Peptide-1 (GLP-1) Therapy in Suboptimally Controlled Type 2 Diabetes: A Randomised Controlled Trial
Presenting Author Piya Sen Gupta City Hospital
Author Russell S Drummond Glasgow Royal Infirmary
Author Barbara MC McGowan Guys and St Thomas' hospital
Author Stephanie A Amiel King's College London
Author Robert EJ Ryder City Hospital
Author Sebastian T Lugg City Hospital
The Honorary Meetings Secretary is an important role within the ABCD Executive. In this position you will be able to channel your passion for diabetes care and education into key ABCD initiatives including our popular Annual Conference and webinar programme.
This is a great developmental opportunity and there is no better way to establish rapport and work with other key stakeholders at a senior level.
You are invited to join the WEDS Spring Meeting on Thursday 25th May at The Miskin Manor Hotel, Mid Glamorgan.
Hosted by the Welsh Endocrine and Diabetes Society (WEDS) with support from the Association of British Diabetologist.
The Guest Speaker for this meeting is Dr Robert Semple from Edinburgh University.
Other speakers are to be confirmed and a full programme is available closer to the date.
This meeting will have 4 CPD points for attendance.
The North European Young Diabetologists (NEYD) Annual Meeting will be held on the 24nd- 26th May 2023 in Denmark.
Abstracts submissions are now open, and close on 24th February 2023.
This consensus statement by the Association of British Clinical Diabetologists and UK Kidney Association provides context and recommendations regarding the use Finerenone in the management of Diabetic Kidney Disease.
EndoBarrier (also known as Duodenal-Jejunal Bypass Liner (DJBL) or RESET®) is a 60cm tube-like liner made from a thin, flexible and durable impermeable polymer. It is inserted by an endoscopy and prevents food that passes through it from contacting the first two feet of small bowel intestine. In clinical trials it leads to weight loss and improved glycaemic control and may become a useful treatment option in the future.
